148 related articles for article (PubMed ID: 24520287)
1. Squamous cell carcinoma with apocrine features of the breast: A case report.
Naito Y; Yamaguchi R; Tanaka M; Saruwatari A; Torii Y; Tsukamoto T; Nishida N; Higaki K
Oncol Lett; 2014 Mar; 7(3):647-650. PubMed ID: 24520287
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative apocrine carcinoma as a rare cause of a breast lump in a Syrian female: a case report and review of the literature.
Ismail S; Kherbek H; Skef J; Zahlouk N; Abdulal R; Alshehabi Z
BMC Womens Health; 2021 Nov; 21(1):396. PubMed ID: 34823507
[TBL] [Abstract][Full Text] [Related]
3. A Case Report on Apocrine Encapsulated Papillary Carcinoma of the Breast with Frank Invasion: A Diagnostic Quandary.
Taniguchi K; Yamasaki R; Kajiwara Y; Ichimura K; Yoshino T
Int J Surg Pathol; 2022 Dec; 30(8):939-944. PubMed ID: 35491656
[TBL] [Abstract][Full Text] [Related]
4. Apocrine carcinoma of the breast.
Yamazaki M; Nagata Y; Monji S; Shigematsu Y; Baba T; Shimokawa H; Uramoto H; Yamada S; Hanagiri T; Tanaka F
J UOEH; 2011 Dec; 33(4):293-301. PubMed ID: 22259834
[TBL] [Abstract][Full Text] [Related]
5. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.
Tsutsumi Y
Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930
[TBL] [Abstract][Full Text] [Related]
6. Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report.
Yang P; Peng SJ; Dong YM; Yang L; Yang ZY; Hu XE; Bao GQ
World J Clin Cases; 2020 Dec; 8(23):6036-6042. PubMed ID: 33344602
[TBL] [Abstract][Full Text] [Related]
7. Mixed Invasive Apocrine Papillary/Micropapillary Carcinoma of the Breast: Another Brick in the Triple-Negative Wall.
Cima L; Mirabassi N; Sartori C; Carbone FG; Morelli L; Cserni G; Barbareschi M
Int J Surg Pathol; 2021 Jun; 29(4):420-426. PubMed ID: 32909476
[TBL] [Abstract][Full Text] [Related]
8. Breast Apocrine Carcinoma Detected Incidentally as Axillary Lymphadenopathy in a CT Scan.
Barron M; Asaad A; Idaewor P; Rasheed N; Saad Abdalla Al-Zawi A
Cureus; 2021 Oct; 13(10):e18523. PubMed ID: 34754678
[TBL] [Abstract][Full Text] [Related]
9. HER2-Positive Metaplastic Spindle Cell Carcinoma Associated with Synchronous Bilateral Apocrine Carcinoma of the Breast.
Kito K; Maeda T; Ninomiya K; Sugita A; Sagawa T; Matsuoka K; Kinoshita K; Hyodo N; Morita N; Furuya K
Case Rep Pathol; 2014; 2014():310829. PubMed ID: 25309767
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous and mammary apocrine carcinomas have different immunoprofiles.
Piris A; Peng Y; Boussahmain C; Essary LR; Gudewicz TM; Hoang MP
Hum Pathol; 2014 Feb; 45(2):320-6. PubMed ID: 24342430
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous adnexal carcinoma with apocrine differentiation.
Prasad V; Kao WH; Kao GF
Cutis; 2016 Dec; 98(6):E16-E19. PubMed ID: 28099545
[TBL] [Abstract][Full Text] [Related]
12. Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.
Mills AM; E Gottlieb C; M Wendroth S; M Brenin C; Atkins KA
Am J Surg Pathol; 2016 Aug; 40(8):1109-16. PubMed ID: 27259012
[TBL] [Abstract][Full Text] [Related]
13. [Morphologic evaluation of papillary carcinoma of the breast featuring expansile invasion].
Yang GZ; Li J; Jin H; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2013 Feb; 42(2):81-5. PubMed ID: 23710912
[TBL] [Abstract][Full Text] [Related]
14. Androgen deprivation by adrenal suppression using low-dose hydrocortisone for the treatment of breast carcinoma with apocrine features: a case report illustrating this new paradigm.
Jongen L; Paridaens R; Floris G; Wildiers H; Neven P
Breast Cancer Res Treat; 2016 Feb; 155(3):603-7. PubMed ID: 26868122
[TBL] [Abstract][Full Text] [Related]
15. [A Case of Apocrine Carcinoma in the Breast That Was Difficult to Distinguish from Axillary Apocrine Adenocarcinoma].
Mori T; Teraoka H; Kinoshita H; Hasegawa T; Noda E; Chikugo T; Kashiwagi S; Hirakawa K; Ohira M
Gan To Kagaku Ryoho; 2018 Dec; 45(13):1961-1963. PubMed ID: 30692411
[TBL] [Abstract][Full Text] [Related]
16. Encapsulated apocrine papillary carcinoma of the breast: case report with clinicopathologic and immunohistochemical study.
Laforga JB; Gasent JM; Sánchez I
Diagn Cytopathol; 2011 Apr; 39(4):288-93. PubMed ID: 20734358
[TBL] [Abstract][Full Text] [Related]
17. Apocrine adenocarcinoma of the breast: A rare special subtype with divergent theranostic markers.
Sujata S; Sudeep K; Taruna Y; Mahendra L
J Cancer Res Ther; 2023; 19(2):477-479. PubMed ID: 37313919
[TBL] [Abstract][Full Text] [Related]
18. Primary squamous cell carcinoma of the breast: a case report.
Liu X; Chen J; Hou C
Discov Oncol; 2024 Apr; 15(1):93. PubMed ID: 38558111
[TBL] [Abstract][Full Text] [Related]
19. IMP3, a proposed novel basal phenotype marker, is commonly overexpressed in adenoid cystic carcinomas but not in apocrine carcinomas of the breast.
Vranic S; Gurjeva O; Frkovic-Grazio S; Palazzo J; Tawfik O; Gatalica Z
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):413-6. PubMed ID: 21436679
[TBL] [Abstract][Full Text] [Related]
20. The role of histopathologic testing on apocrine carcinoma of the breast.
Ilhan B; Emiroğlu S; Türkay R; Ilhan R
Curr Probl Cancer; 2020 Apr; 44(2):100501. PubMed ID: 31521370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
